✦ LIBER ✦

Intratracheal Administration of Endotoxin and Cytokines: VII. The Soluble Interleukin-1 Receptor and the Soluble Tumor Necrosis Factor Receptor II (p80) Inhibit Acute Inflammation

✍ Scribed by Thomas R. Ulich; Eunhee S. Yi; Songmei Yin; Craig Smith; Daniel Remick

Book ID: 112240540
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 257 KB
Volume: 72
Category: Article
ISSN: 1090-2341
DOI: 10.1006/clin.1994.1117

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Analysis of tumor necrosis factor-α, int

Analysis of tumor necrosis factor-α, interleukin-6, interleukin-1β, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor, interleukin-1 soluble receptor type II, interleukin-1 receptor antagonist, and protein in the synovial fluid of patients with temporomandibular joint disorders

✍ Keiseki Kaneyama; Natsuki Segami; Wei Sun; Jun Sato; Kazuma Fujimura 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 261 KB

Influence of hypercortisolemia on solubl

Influence of hypercortisolemia on soluble tumor necrosis factor receptor II and interleukin-1 receptor antagonist responses to endotoxin in human beings

✍ Annabel E. Barber; Susette M. Coyle; Eva Fischer; Christopher Smith; Tom van der 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 504 KB

Effects of soluble interleukin-1 recepto

Effects of soluble interleukin-1 receptor and tumor-necrosis factor receptor, respectively, on the IL-1- and TNF-α-induced DNA synthesis of acute myeloblastic leukemia blasts in vitro

✍ Anna Carter; Nuhad Haddad; Ilana Draxler; Ilana Tatarsky 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 719 KB

Combination benefit of treatment with th

Combination benefit of treatment with the cytokine inhibitors interleukin-1 receptor antagonist and PEGylated soluble tumor necrosis factor receptor type I in animal models of rheumatoid arthritis

✍ Alison M. Bendele; Elizabeth S. Chlipala; Jon Scherrer; Janet Frazier; Gina Senn 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 695 KB

Objective. To determine the potential for additive or synergistic effects of combination therapy with the recombinant anticytokine agents interleukin-1 receptor antagonist (IL-1Ra) and PEGylated soluble tumor necrosis factor receptor type I (PEG sTNFRI) in established type II collagen-induced arthri

Role of cytokines (interleukin-1β, 6, 8,

Role of cytokines (interleukin-1β, 6, 8, tumour necrosis factor-α, and soluble receptor of interleukin-2) and C-reactive protein in the diagnosis of neonatal sepsis

✍ C Santana Reyes; F García-Muñoz; D Reyes; G González; C Dominguez; E Domenech 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB